Cited by 217Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementAcute Ischemic Stroke Management

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

Hughes, M., Lip, G.Y.H., on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care·2007·QJM

DOI 10.1093/qjmed/hcm076

Open this paper in CoChat — free account

Abstract

Atrial fibrillation (AF) is associated with an increased stroke risk that may be reduced by therapeutic anticoagulation. However, anticoagulation is associated with an increased risk of bleeding that in some patients may outweigh the benefits in reducing the risk of stroke. We systematically reviewed the literature for risk factors of anticoagulation-related bleeding complications in patients with AF, as part of the formulation of recently published national guidelines for the management of AF. We identified nine studies that reported anticoagulation-related bleeding complications in AF patients. The following patient characteristics were identified as having supporting evidence for being risk factors for anticoagulation-related bleeding complications: advanced age, uncontrolled hypertension, history of myocardial infarction or ischaemic heart disease, cerebrovascular disease, anaemia or a history of bleeding, and the concomitant use of other drugs such as antiplatelet agents. The presence of diabetes mellitus, controlled hypertension and gender were not identified as significant risk factors. Some of the risk factors for anticoagulation-related bleeding are also indications for the use of anticoagulants in AF patients. There is a need for further research in this area to help physicians to balance the risks and benefits of anticoagulation in AF patients.

Integrity signals

Registry

Crossref · 10.1093/qjmed/hcm076

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,636
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,362
A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community
Wang, T. J., Massaro, J. M., Levy, D. A., Vasan, R. S., Wolf, P. A., D’Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 790
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · EP Europace · doi:10.1093/europace/eul097 · Cited by 670
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
Hart, R. G., Pearce, L. A., Rothbart, R. M., McAnulty, J. H., ASINGER, R. W., & Halperin, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00489-1 · Cited by 662
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary
Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 646
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.429s · Cited by 547

Show all 36 references

Sorted by citations

Items 101–200 of 217

Risk factors associated with post-extraction bleeding in patients on warfarin or direct-acting oral anticoagulants: a retrospective cohort study
Iwata, E., Tachibana, A., Kusumoto, J., Hasegawa, T., Kadoya, R., Enomoto, Y., Takata, N., & Akashi, M. (2022) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-022-01039-0 · Cited by 12
Warfarin Anticoagulation After Congenital Heart Surgery at a Large Children’s Hospital
Lowry, A. W., Moffett, B. S., Moodie, D. S., & Knudson, J. D. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0351-3 · Cited by 12
Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
Carrasco‐Garrido, P., Hernández‐Barrera, V., Esteban‐Hernández, J., Jiménez‐Trujillo, I., Álvaro‐Meca, A., López‐de‐Andrés, A., de Miguel‐Díez, J., Barrios, J. M. R., Robles, J. A. M., & Jiménez‐García, R. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013224 · Cited by 12
Incidence, risk factors, and outcomes of warfarin‐associated major bleeding in Thai population
Priksri, W., Rattanavipanon, W., Saejear, W., Tanyasaensook, K., Phrommintikul, A., Chulavatnatol, S., & Nathisuwan, S. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4781 · Cited by 12
To Treat or Not to Treat
Appelros, P., Farahmand, B. Y., Terént, A., & Åsberg, S. (2017) · Stroke · doi:10.1161/strokeaha.117.016902 · Cited by 11
Management of antithrombotic therapy in patients undergoing dental procedures
Curtis, J., Henderson, D. P., Zarghami, M., Rashedi, S., & Bikdeli, B. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.09.022 · Cited by 15
2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
Lee, J., Joung, B., Cha, M., Lee, J. H., Lim, W., Kim, T., Shin, S. Y., Uhm, J., Lim, H. E., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.87.e1 · Cited by 11
Leaks after left atrial appendage ligation with Lariat device: Incidence, pathophysiology, clinical implications and methods of closure- A case based discussion
Yarlagadda, B., Parikh, V. K., Dar, T. A., & Lakkireddy, D. (2017) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1725 · Cited by 11
Prediction Model for Significant Bleeding in Patients with Supratherapeutic International Normalized Ratio After Oral Administration of Warfarin
Pourafkari, L., Baghbani‐Oskouei, A., Savadi, S., Ghaffari, S., Parizad, R., Tajlil, A., & Nader, N. D. (2019) · Clinical Drug Investigation · doi:10.1007/s40261-019-00774-9 · Cited by 10
Prevention of Stroke in Patients with Atrial Fibrillation: The Role of New Antiarrhythmic and Antithrombotic Drugs
Röther, J., & Crijns, H. J. G. M. (2010) · Cerebrovascular Diseases · doi:10.1159/000319608 · Cited by 9
Trajectories of Oral Anticoagulation Adherence and Associated Clinical Outcomes During Long-Term Anticoagulation Among Medicare Beneficiaries With Venous Thromboembolism
Park, H., Jones, B. L., Huang, P., Kang, H., Dietrich, E. A., DeRemer, C. E., & Lo‐Ciganic, W. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231155489 · Cited by 10
Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients
Sofjan, A. K., Melaragno, J. I., Bain, K. B., Deal, E. N., Witt, C. A., Hachem, R. R., & Yusen, R. D. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016656434 · Cited by 9
A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant – Has venous thromboembolism treatment become safer?
Lui, B., Wee, B., Lai, J., Khattak, Z., Kwok, A., Donarelli, C., Ho, P. W., & Lim, H. Y. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.09.006 · Cited by 11
Diagnosis and treatment of atrial fibrillation in the acute care setting
Nottingham, F. (2010) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2010.00508.x · Cited by 9
Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range
Taggar, J., & Lip, G. Y. H. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x301875 · Cited by 9
Self-citation
What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?
Velu, S., & Lip, G. Y. H. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0091-9 · Cited by 8
Self-citation
Predictors of hospital mortality and serious complications in patients admitted with excessive warfarin anticoagulation
Pourafkari, L., Ghaffari, S., Khaki, N., Hobika, G. G., Shirazi, K. M., & Nader, N. D. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.11.014 · Cited by 8
2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
Lee, J., Joung, B., Cha, M., Lee, J. H., Lim, W., Kim, T., Shin, S. Y., Uhm, J., Lim, H. E., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.87 · Cited by 8
Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review
Chen, W. T., White, C. M., Phung, O. J., Kluger, J., Ashaye, A. O., Sobieraj, D. M., Makanji, S. S., Tongbram, V., Baker, W. L., & Coleman, C. I. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02694.x · Cited by 9
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion
García-Fernández, A., Marín, F. R., Roldán, V., Galcerá-Jornet, E., Martı́nez, J. G., Valdés, M., Sogorb, F., & Lip, G. Y. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.167 · Cited by 8
Self-citation
Biomarkers Associated with Bleeding Risk in the Setting of Atrial Fibrillation
Sideris, S. K., Archontakis, S., Latsios, G., Lazaros, G. A., Toutouzas, K. P., Tsiamis, E. G., Vavuranakis, M., Vlachopoulos, C., Gatzoulis, K. A., Tsioufis, C., et al. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170718124742 · Cited by 8
Left Atrial Occlusion Device Implantation: the Role of the Echocardiographer
Altszuler, D., Vainrib, A., Bamira, D. G., Benenstein, R., Aizer, A., Chinitz, L. A., & Sarić, M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1151-7 · Cited by 8
What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
Lip, G. Y. H. (2012) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2012.s04 · Cited by 7
Self-citation
Estimation of clinical and economic effects of prophylaxis against venous thromboembolism in medical patients, including the effect of targeting patients at high‐risk
Millar, J. A., & Gee, A. (2016) · Internal Medicine Journal · doi:10.1111/imj.12995 · Cited by 7
Effectiveness and Safety of Extended Oral Anticoagulant Therapy in Patients with Venous Thromboembolism: A Retrospective Cohort Study
Kang, H., Lo‐Ciganic, W., DeRemer, C. E., Dietrich, E. A., Huang, P., & Park, H. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2611 · Cited by 7
Challenges facing anticoagulation among the elderly and frail
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2008) · Age and Ageing · doi:10.1093/ageing/afn295 · Cited by 7
Self-citation
Meta-analysis of Safety and Efficacy of Anticoagulation versus no Anticoagulation in Octogenarians and Nonagenarians with Atrial Fibrillation
Barssoum, K. N., Kumar, A., Thakkar, S. J., Sheth, A. R., Kharsa, A., Ibrahim, M., Rai, D., Idemudia, O., Akula, N., Patel, H., et al. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00442-0 · Cited by 6
Eligibility for medical thromboprophylaxis based on risk‐factor weights, and clinical thrombotic event rates
Millar, J. A., Lett, J. E., Bagley, L. J., & Densie, I. K. (2012) · The Medical Journal of Australia · doi:10.5694/mja11.10737 · Cited by 6
Spontaneous Esophageal Hematoma in a Patient With Atrial Fibrillation
Guzman, R., Ding, L., Watson, T. J., Hobbs, S. K., & Litle, V. R. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.07.063 · Cited by 6
Stroke prevention in atrial fibrillation patients
Marinigh, R., Lip, G. Y. H., & Lane, D. A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.498819 · Cited by 6
Self-citation
Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis
Dawwas, G. K., Dietrich, E. A., Smith, S. M., Davis, K., & Park, H. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.06.022 · Cited by 6
Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study
Gaio, M., Ferrajolo, C., Zinzi, A., Riccardi, C., Filippo, P. D., Carangelo, L., Pieretti, G., Rossi, F., Nicoletti, G. F., & Capuano, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.790740 · Cited by 6
The Link Between Hypertension and Stroke: Summary of Observational Epidemiological Studies
Soga, Y., & Pandey, D. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-010-6_2 · Cited by 6
Trajectories of adherence to extended treatment with direct oral anticoagulants and risks of recurrent venous thromboembolism and major bleeding
Kang, H., Jones, B. L., Lo‐Ciganic, W., DeRemer, C. E., Dietrich, E. A., Huang, P., Wilson, D. L., & Park, H. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.11.1219 · Cited by 5
The Hemorrhagic Risk: How to Evaluate It
Fusco, S. A. D., Colivicchi, F., & Santini, M. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12146 · Cited by 5
Managing oral anticoagulation therapy by pharmacists in a specialty heart hospital
Patel‐Naik, B., Szeinbach, S. L., Seoane-Vazquez, E. C., Snider, M. J., & Hevezi, M. S. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01110.x · Cited by 5
DOACs for Older adults with Atrial Fibrillation and Falls: Results from the prospective single-centre DOAFF study
Catalani, F., Patetta, L. M. A., Campello, E., Fino, R., Novello, S., Occhipinti, G., Zanforlini, B. M., Simioni, P., & Sergi, G. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.04.023 · Cited by 4
Novel oral anticoagulants for stroke prevention in atrial fibrillation: Key trial findings and clinical implications
Goette, A. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.10.001 · Cited by 4
Knowledge, Adherence, and Quality of Life among Warfarin Therapy Users
Matalqah, L. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86371 · Cited by 4
Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis
Suah, B.-H., Lee, Z.-Y., Teo, Y. H., Teo, Y. N., Syn, N. L. X., Soh, R. Y.-H., Yeo, L. L. L., Tan, B. Y., Ho, J. S. Y., Li, T. Y., et al. (2022) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-022-00530-z · Cited by 4
Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
Park, H., Kang, H., Huang, P., Lo‐Ciganic, W., DeRemer, C. E., Wilson, D. L., & Dietrich, E. A. (2022) · Clinical and Translational Science · doi:10.1111/cts.13433 · Cited by 3
Stroke-Specific Predictors of Major Bleeding in Anticoagulated Patients With Stroke and Atrial Fibrillation: A Nationwide Multicenter Registry-Based Study
Chung, D., Song, T., Kim, B. J., Heo, S. H., Jung, J., Oh, K., Kim, C. K., Yu, S., Park, K., Kim, J., et al. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.0289 · Cited by 4
Estratificación del riesgo hemorrágico en el síndrome coronario agudo
Mateo-Martínez, A., Marín, F. R., Roldán, V., Hernández‐Romero, D., Hurtado, J. A., & Valdés, M. (2010) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(10)70030-3 · Cited by 4
Generative statistical modeling of left atrial appendage appearance to substantiate clinical paradigms for stroke risk stratification
Sanatkhani, S., & Menon, P. G. (2018) · SPIE Medical Imaging: Image Processing · doi:10.1117/12.2291568 · Cited by 4
Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation and Hypertension: A Meta-Analysis
Zheng, Y., Liu, Y., Bi, J., Lai, W., Lin, C., Zhu, J., Yao, W., & Chen, Q. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00342-8 · Cited by 4
The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn.
Reiffel, J. A. (2010) · Europe PMC (PubMed Central) · doi:10.4022/jafib.304 · Cited by 4
Clinical predictors of warfarin-associated bleeding: A case-control study
Hussain, S. J., Deepanjali, S., & Munuswamy, H. (2024) · Tropical Doctor · doi:10.1177/00494755241287952 · Cited by 3
Stroke Prevention Treatment of Patients with Atrial Fibrillation: Old and New
Bal, S. S., Ojha, P., & Hill, M. D. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0161-z · Cited by 3
Recent Progress in Antithrombotic Therapy for Atrial Fibrillation
Velu, S., & Lip, G. Y. H. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7153 · Cited by 3
Self-citation
Percutaneous Left Atrial Appendage Closure Devices
Vainrib, A., Bamira, D. G., & Sarić, M. (2017) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-017-9437-x · Cited by 3
Antithrombotic Therapy in Atrial Fibrillation
Lee, P. C. (2012) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2012.09.001 · Cited by 3
Preventative Measures of Stroke in Patients With Atrial Fibrillation.
Adlan, A., & Lip, G. Y. H. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.399 · Cited by 2
Self-citation
Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage
Schaub, F., Polymeris, A. A., Schaedelin, S., Hert, L., Meya, L., Thilemann, S., Traenka, C., Wagner, B., Seiffge, D. J., Gensicke, H., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.023345 · Cited by 2
Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.
Schaub, F., Polymeris, A. A., Schaedelin, S. A., Hert, L., Meya, L., Thilemann, S., Traenka, C., Wagner, B., Seiffge, D. J., Gensicke, H., et al. (2022) · doi:10.48350/163852 · Cited by 2
Factors Correlated with Anticoagulation Choice in Primary Care Patients with Atrial Fibrillation and High Stroke Risk
Weng, C., Kuo, H., Aho, B., McGookin, E. D., & Chan, P. A. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08871-y · Cited by 2
The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
Pamukçu, B., Lane, D. A., & Lip, G. Y. H. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.153 · Cited by 2
Self-citation
Case 4–2015
Lanigan, M. J., Chaney, M. A., Nathan, S., Shah, A. P., & Feider, A. J. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.06.030 · Cited by 2
New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation
Kuzniatsova, N., & Lip, G. Y. H. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.150 · Cited by 2
Self-citation
Measures of risk and their relationship to the relative size of a high-risk group: application to medical thromboprophylaxis
Millar, J. A. (2012) · Clinical Epidemiology · doi:10.2147/clep.s37527 · Cited by 2
Characteristics, treatment patterns, and unmet needs of Japanese patients with atrial fibrillation
DiBonaventura, M., Koretsune, Rossi, Iwamoto, K., Wang, & Brière (2013) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s45200 · Cited by 2
Efficacy and Safety of Warfarin Experience in a Stroke Polyclinic in Stroke Patients
Çoban, E., Kırbaş, D., Ataklı, D., & Soysal, A. (2016) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.15951 · Cited by 2
Long-Term Prognosis after Transient Ischemic Attack and Stroke
Lau, G. K. K., Pendlebury, S. T., & Rothwell, P. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316161609.018 · Cited by 2
Predicción y tratamiento de la hemorragia en pacientes anticoagulados
Páramo, J. A. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.06.065 · Cited by 2
Study of patients with iron deficiency and HF in Ireland: prevalence and treatment budget impact
Wong, B., Redmond, S., Blaine, C., Nugent, C.-A., Saiva, L., Buckley, J., & O'Neill, J. O. (2021) · British Journal of Cardiology · doi:10.5837/bjc.2021.010 · Cited by 2
Magnitude of hemorrhagic complications and its associated factors among patients on anticoagulant therapy at University of Gondar Comprehensive and Specialized Hospital, Northwest Ethiopia
Mehari, E. A., Mekuria, A. B., Geta, M., & Birru, E. M. (2023) · Thrombosis Update · doi:10.1016/j.tru.2023.100130 · Cited by 2
Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants
Martínez, C. C., Ruíz, G. E., Blanco, P. J. F., Manchado, J. J. C., Iglesias, H. A., Navarro, A. L., Montoya, F. A., Garcı́a-Alberola, A., Pascual-Figal, D. A., Lorenzo, J. L. B., et al. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.08.026 · Cited by 2
Management of atrial fibrillation – Authors' reply
Lip, G. Y. H., & Tse, H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61683-3 · Cited by 2
Self-citation
Bleeding risk during oral anticoagulation therapy for atrial fibrillation
Gallego, P., Lip, G. Y. H., & Lane, D. A. (2013) · EP Europace · doi:10.1093/europace/eut061 · Cited by 2
Self-citation
Postoperative Lung Transplant Considerations in the Older Recipient
Hanna, S., Beermann, K. J., Levine, D. J., Loor, G., Singer, J. P., Smith, P. J., & Ali, H. A. (2025) · CHEST Journal · doi:10.1016/j.chest.2024.10.060 · Cited by 1
Prescribing Anticoagulation Medication for the Elderly
Palareti, G., & Cosmi, B. (2012) · Aging Health · doi:10.2217/ahe.12.11 · Cited by 1
The burden of atrial fibrillation
Weidtmann, B., Demming, T., & Bonnemeier, H. (2010) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-010-0002-2 · Cited by 1
Atrial Fibrillation and Percutaneous Coronary Intervention: Stroke, Thrombosis, and Bleeding
Gutiérrez, A., & Rao, S. V. (2011) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-011-0120-2 · Cited by 1
Emergent Reversal of Oral Anticoagulation
Straznitskas, A., & Giarratano, M. (2014) · AACN Advanced Critical Care · doi:10.1097/nci.0000000000000000 · Cited by 1
Prevalencia e implicación pronóstica de la enfermedad valvular en pacientes con fibrilación auricular que inician anticoagulantes orales
Martínez, C. C., Ruíz, G. E., Flores‐Blanco, P. J., Manchado, J. J. C., Iglesias, H. A., Navarro, A. L., Montoya, F. A., Alberola, A. G., Pascual-Figal, D. A., Lorenzo, J. L. B., et al. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.08.006 · Cited by 1
Drug-induced intracerebral hemorrhage
Листратов, А. И., Оstroumova, Т. М., Кочетков, А. И., & Ostroumova, O. D. (2022) · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · doi:10.37489/2588-0519-2022-2-55-68 · Cited by 1
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
Ostroumova, O. D., Листратов, А. И., Оstroumova, Т. М., Кочетков, А. И., & Sychev, D. A. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-6-80-88 · Cited by 1
Hemostatic Aspects of Cardiovascular Medicine
Vemulapalli, S., & Becker, R. C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00021-x · Cited by 1
Anticoagulação em gestantes com prótese valvar mecânica
Cavalcante, J. L., Nobre, M. D. N., Sena, R. G., Cavalcante, J. W. D. S., de Magalhães, R. T., & Luna, F. M. S. (2019) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e446.2019 · Cited by 1
PREDICTORS OF MAJOR BLEEDING AMONG ATRIAL FIBRILLATION PATIENTS ON WARFARIN
Matalqah, L. M., Yehya, A., & Al‐Taani, G. M. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2019.v12i2.29955 · Cited by 1
Prediction and treatment of bleeding in patients under anticoagulant treatment
Páramo, J. A. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.06.031 · Cited by 1
Frequency of bleeding complications in Algerian patients treated with the vitamin K antagonist acenocoumarol and associated factors
Belkacemi, M., Merad, Y., & Berber, A. (2021) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20214062 · Cited by 1
Risk of hemorrhagic stroke after venomous snakebite: correspondence
Yeh, W. B., Lee, W. K., Jou, I. M., & Chou, M. C. (2022) · QJM · doi:10.1093/qjmed/hcac130 · Cited by 1
AZD6140 and bleeding: towards safer antiplatelet therapy?
Siddique, A., Shantsila, E., & Lip, G. Y. H. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01963.x · Cited by 1
Self-citation
Risk factors for anticoagulation-related bleeding complications
Jolobe, O. M. P. (2008) · QJM · doi:10.1093/qjmed/hcm144 · Cited by 1
Fibrillation auriculaire: quels patients doivent être anticoagulés par voie orale, lesquels non?
Bucher, U., Schaer, B. A., Sticherling, C., & Osswald, S. (2009) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2009.06836
Atrial Fibrillation: Non Surgical Management
Khoo, C. W., & Lip, G. Y. H. (2010) · Springer eBooks · doi:10.1007/978-1-84996-426-5_13
Self-citation
Bleeding risk with oral anticoagulation - new frontiers and new questions
Banerjee, A., Lane, D. A., & Lip, G. Y. H. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02716.x
Self-citation
Antithrombotic management of atrial fibrillation
Pisters, R., & Crijns, H. J. G. M. (2012) · doi:10.2217/ebo.12.118
Understanding adipokine secretion and adipocyte-macrophage cellular interactions, in search for the molecular basis of insulin sensitivity and resistance
Xie, L. (2008) · K-State Research Exchange (Kansas State University)
The Experience of Primary Healthcare patients who take Warfarin in New Zealand
Currie, G. R. (2012) · Otago University Research Archive (University of Otago)
Fibrillation atriale : qui anticoaguler ?
Césari, O. (2010) · La Presse Médicale · doi:10.1016/j.lpm.2010.03.005
Stroke and Bleeding Risks in Patients with Atrial Fibrillation
Maan, A., Ruskin, J. N., & Heist, E. K. (2014) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2013.11.001
Indicaciones de la anticoagulación en pacientes con diabetes
Muñoz, M. S. G., Bañares, M. J. B., & Pastor, Á. L. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)61003-4
Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice
Khoo, C. W., & Lip, G. Y. H. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03115.x
Self-citation
Use of secondary preventive drugs after stroke
Sjölander, M. (2013) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Polypharmacy in geriatric patients: too little or too much?
Tulner, C. R. (2009) · Utrecht University Repository (Utrecht University)
Caracterización biológica y clínica del riesgo trombótico y hemorrágico de pacientes con fibrilación auricular no valvular bajo tratamiento anticoagulante oral.
Hernanz, G., & Pilar, M. D. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Antithrombotic Issues in Women
Muñiz‐Lozano, A., Rollini, F., Franchi, F., Cho, J. R., & Angiolillo, D. J. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5517-1_15
Type the Characteristics of Pacemaker (PM) Patients Admitted in Stroke Unit: The Stroke Pacemaker Study (SPACES)
Spinelli, M. (2014) · International Blood Research & Reviews · doi:10.9734/ibrr/2014/5693
Cardiovascular Clinical Trials
(2012) · Wiley eBooks · doi:10.1002/9781118399378

Authors: Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care
Affiliations: Royal College of Physicians (GB)
Birmingham City Hospital (GB)
ORCID: Lip, G.Y.H.
Venue: QJM
Publisher: Oxford University Press (OUP)
Published: 2007-09-19
Volume: 100
Issue: 10
Pages: 599-607
ISSN: 0033-5622 (ISSN-L)
1460-2725
1460-2393
DOI: 10.1093/qjmed/hcm076
OpenAlex: W2128635858
Cited by: 217
References: 36
Citations by year: 2025: 1 · 2024: 5 · 2023: 4 · 2022: 13 · 2021: 8 · 2020: 4 · 2019: 11 · 2018: 12 · 2017: 12 · 2016: 13 · 2015: 5 · 2014: 11 · 2013: 23 · 2012: 28
FWCI: 2.42
Type: journal article
Language: en
Open access: closed
Locations: QJM (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: National Institutes of Health
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: atrial fibrillation, anticoagulation, bleeding complications, risk factors, stroke prevention, antiplatelet agents, hypertension, myocardial infarction, anemia, old age, concomitant drug use, benefits and risks
MeSH terms: Age Factors, Anticoagulants, Atrial Fibrillation, Female, Hemorrhage, Humans, Male, Risk Factors, Sex Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks